Federation des caisses Desjardins du Quebec’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $365K | Sell |
10,129
-67,302
| -87% | -$2.42M | ﹤0.01% | 1099 |
|
2025
Q1 | $2.41M | Buy |
77,431
+1,282
| +2% | +$39.9K | 0.01% | 559 |
|
2024
Q4 | $1.94M | Sell |
76,149
-32,397
| -30% | -$826K | 0.01% | 592 |
|
2024
Q3 | $3.07M | Buy |
108,546
+1,286
| +1% | +$36.3K | 0.02% | 456 |
|
2024
Q2 | $2.83M | Sell |
107,260
-3,893
| -4% | -$103K | 0.02% | 473 |
|
2024
Q1 | $3.13M | Buy |
111,153
+3,001
| +3% | +$84.5K | 0.02% | 414 |
|
2023
Q4 | $3.04M | Hold |
108,152
| – | – | 0.03% | 351 |
|
2023
Q3 | $2.94M | Sell |
108,152
-8,028
| -7% | -$218K | 0.03% | 342 |
|
2023
Q2 | $3.57M | Sell |
116,180
-76,935
| -40% | -$2.36M | 0.04% | 342 |
|
2023
Q1 | $6.96M | Buy |
+193,115
| New | +$6.96M | 0.08% | 204 |
|
2022
Q4 | – | Sell |
-149,992
| Closed | -$6.03M | – | 2535 |
|
2022
Q3 | $6.03M | Buy |
149,992
+444
| +0.3% | +$17.8K | 0.07% | 207 |
|
2022
Q2 | $6.29M | Buy |
149,548
+126,358
| +545% | +$5.31M | 0.07% | 210 |
|
2022
Q1 | $903K | Buy |
23,190
+21,491
| +1,265% | +$837K | 0.01% | 675 |
|
2021
Q4 | $67.7K | Hold |
1,699
| – | – | ﹤0.01% | 1508 |
|
2021
Q3 | $61.3K | Buy |
1,699
+394
| +30% | +$14.2K | ﹤0.01% | 1544 |
|
2021
Q2 | $53.4K | Hold |
1,305
| – | – | ﹤0.01% | 1592 |
|
2021
Q1 | $57K | Hold |
1,305
| – | – | ﹤0.01% | 1506 |
|
2020
Q4 | $65.3K | Buy |
+1,305
| New | +$65.3K | ﹤0.01% | 1410 |
|